Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugs
Novel treatment options are needed for the successful therapy of patients with high-risk neuroblastoma. Here, we investigated the cyclin-dependent kinase (CDK) inhibitor SNS-032 in a panel of 109 neuroblastoma cell lines consisting of 19 parental cell lines and 90 sublines with acquired resistance t...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2013
|
| In: |
Translational oncology
Year: 2014, Jahrgang: 6, Heft: 6, Pages: 685-696 |
| ISSN: | 1936-5233 |
| DOI: | 10.1593/tlo.13544 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1593/tlo.13544 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1936523313800083 
|
| Verfasserangaben: | Nadine Löschmann, Martin Michaelis, Florian Rothweiler, Richard Zehner, Jaroslav Cinatl, Yvonne Voges, Mohsen Sharifi, Kristoffer Riecken, Jochen Meyer, Andreas von Deimling, Iduna Fichtner, Taravat Ghafourian, Frank Westermann and Jindrich Cinatl |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 175835206X | ||
| 003 | DE-627 | ||
| 005 | 20250323023335.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210521r20132014xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1593/tlo.13544 |2 doi | |
| 035 | |a (DE-627)175835206X | ||
| 035 | |a (DE-599)KXP175835206X | ||
| 035 | |a (OCoLC)1341413825 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Löschmann, Nadine |e VerfasserIn |0 (DE-588)1233904035 |0 (DE-627)1758353430 |4 aut | |
| 245 | 1 | 0 | |a Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugs |c Nadine Löschmann, Martin Michaelis, Florian Rothweiler, Richard Zehner, Jaroslav Cinatl, Yvonne Voges, Mohsen Sharifi, Kristoffer Riecken, Jochen Meyer, Andreas von Deimling, Iduna Fichtner, Taravat Ghafourian, Frank Westermann and Jindrich Cinatl |
| 264 | 1 | |c 2013 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 19 February 2014 | ||
| 500 | |a Gesehen am 21.05.2021 | ||
| 520 | |a Novel treatment options are needed for the successful therapy of patients with high-risk neuroblastoma. Here, we investigated the cyclin-dependent kinase (CDK) inhibitor SNS-032 in a panel of 109 neuroblastoma cell lines consisting of 19 parental cell lines and 90 sublines with acquired resistance to 14 different anticancer drugs. Seventy-three percent of the investigated neuroblastoma cell lines and all four investigated primary tumor samples displayed concentrations that reduce cell viability by 50% in the range of the therapeutic plasma levels reported for SNS-032 (<754 nM). Sixty-two percent of the cell lines and two of the primary samples displayed concentrations that reduce cell viability by 90% in this concentration range. SNS-032 also impaired the growth of the multidrug-resistant cisplatin-adapted UKF-NB-3 subline UKF-NB-3rCDDP1000 in mice. ABCB1 expression (but not ABCG2 expression) conferred resistance to SNS-032. The antineuroblastoma effects of SNS-032 did not depend on functional p53. The antineuroblastoma mechanism of SNS-032 included CDK7 and CDK9 inhibition-mediated suppression of RNA synthesis and subsequent depletion of antiapoptotic proteins with a fast turnover rate including X-linked inhibitor of apoptosis (XIAP), myeloid cell leukemia sequence 1 (Mcl-1), baculoviral IAP repeat containing 2 (BIRC2; cIAP-1), and survivin. In conclusion, CDK7 and CDK9 represent promising drug targets and SNS-032 represents a potential treatment option for neuroblastoma including therapy-refractory cases. | ||
| 534 | |c 2014 | ||
| 700 | 1 | |8 1\p |a Michaelis, Martin |d 1972- |e VerfasserIn |0 (DE-588)123434831 |0 (DE-627)082554315 |0 (DE-576)293708096 |4 aut | |
| 700 | 1 | |8 2\p |a Rothweiler, Florian |d 1978- |e VerfasserIn |0 (DE-588)143034790 |0 (DE-627)641857292 |0 (DE-576)334696992 |4 aut | |
| 700 | 1 | |8 3\p |a Zehner, Richard |d 1965- |e VerfasserIn |0 (DE-588)121403289 |0 (DE-627)705436187 |0 (DE-576)292691920 |4 aut | |
| 700 | 1 | |a Cinatl, Jaroslav |e VerfasserIn |4 aut | |
| 700 | 1 | |a Voges, Yvonne |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sharifi, Mohsen |e VerfasserIn |4 aut | |
| 700 | 1 | |8 4\p |a Riecken, Kristoffer |e VerfasserIn |0 (DE-588)1045248657 |0 (DE-627)773951164 |0 (DE-576)398864934 |4 aut | |
| 700 | 1 | |a Meyer, Jochen |e VerfasserIn |0 (DE-588)1136398953 |0 (DE-627)89281201X |0 (DE-576)490511716 |4 aut | |
| 700 | 1 | |a Deimling, Andreas von |d 1959- |e VerfasserIn |0 (DE-588)103034115X |0 (DE-627)735093946 |0 (DE-576)378138065 |4 aut | |
| 700 | 1 | |a Fichtner, Iduna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ghafourian, Taravat |e VerfasserIn |4 aut | |
| 700 | 1 | |a Westermann, Frank |d 1968- |e VerfasserIn |0 (DE-588)118119990 |0 (DE-627)69468628X |0 (DE-576)291725570 |4 aut | |
| 700 | 1 | |8 5\p |a Cinatl, Jindrich |e VerfasserIn |0 (DE-588)1275992072 |0 (DE-627)186085298X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Translational oncology |d Ann Arbor, Mich. : [Verlag nicht ermittelbar], 2008 |g 6(2013), 6 vom: Dez., Seite 685-696 |h Online-Ressource |w (DE-627)57436482X |w (DE-600)2443840-6 |w (DE-576)28492945X |x 1936-5233 |7 nnas |a Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugs |
| 773 | 1 | 8 | |g volume:6 |g year:2013 |g number:6 |g month:12 |g pages:685-696 |g extent:12 |a Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugs |
| 856 | 4 | 0 | |u https://doi.org/10.1593/tlo.13544 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1936523313800083 |x Verlag |z lizenzpflichtig |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20250301 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 2\p |a cgwrk |d 20250301 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 3\p |a cgwrk |d 20250301 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 4\p |a cgwrk |d 20250301 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 5\p |a cgwrk |d 20250301 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20210521 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 118119990 |a Westermann, Frank |m 118119990:Westermann, Frank |d 50000 |e 50000PW118119990 |k 0/50000/ |p 13 | ||
| 998 | |g 103034115X |a Deimling, Andreas von |m 103034115X:Deimling, Andreas von |d 910000 |d 912000 |e 910000PD103034115X |e 912000PD103034115X |k 0/910000/ |k 1/910000/912000/ |p 10 | ||
| 999 | |a KXP-PPN175835206X |e 3930255340 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugs","title_sort":"Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugs"}],"language":["eng"],"physDesc":[{"extent":"12 S."}],"note":["Available online 19 February 2014","Gesehen am 21.05.2021"],"name":{"displayForm":["Nadine Löschmann, Martin Michaelis, Florian Rothweiler, Richard Zehner, Jaroslav Cinatl, Yvonne Voges, Mohsen Sharifi, Kristoffer Riecken, Jochen Meyer, Andreas von Deimling, Iduna Fichtner, Taravat Ghafourian, Frank Westermann and Jindrich Cinatl"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"recId":"175835206X","id":{"eki":["175835206X"],"doi":["10.1593/tlo.13544"]},"person":[{"role":"aut","display":"Löschmann, Nadine","family":"Löschmann","given":"Nadine"},{"role":"aut","display":"Michaelis, Martin","family":"Michaelis","given":"Martin"},{"display":"Rothweiler, Florian","family":"Rothweiler","role":"aut","given":"Florian"},{"given":"Richard","display":"Zehner, Richard","family":"Zehner","role":"aut"},{"given":"Jaroslav","family":"Cinatl","display":"Cinatl, Jaroslav","role":"aut"},{"given":"Yvonne","role":"aut","family":"Voges","display":"Voges, Yvonne"},{"role":"aut","family":"Sharifi","display":"Sharifi, Mohsen","given":"Mohsen"},{"given":"Kristoffer","display":"Riecken, Kristoffer","family":"Riecken","role":"aut"},{"role":"aut","family":"Meyer","display":"Meyer, Jochen","given":"Jochen"},{"given":"Andreas von","role":"aut","family":"Deimling","display":"Deimling, Andreas von"},{"given":"Iduna","family":"Fichtner","display":"Fichtner, Iduna","role":"aut"},{"role":"aut","display":"Ghafourian, Taravat","family":"Ghafourian","given":"Taravat"},{"given":"Frank","role":"aut","display":"Westermann, Frank","family":"Westermann"},{"role":"aut","display":"Cinatl, Jindrich","family":"Cinatl","given":"Jindrich"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"57436482X","disp":"Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugsTranslational oncology","part":{"volume":"6","pages":"685-696","year":"2013","extent":"12","issue":"6","text":"6(2013), 6 vom: Dez., Seite 685-696"},"pubHistory":["1.2008 -"],"id":{"issn":["1936-5233"],"zdb":["2443840-6"],"eki":["57436482X"]},"origin":[{"publisherPlace":"Ann Arbor, Mich.","dateIssuedKey":"2008","dateIssuedDisp":"2008-","publisher":"[Verlag nicht ermittelbar]"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Translational oncology","title":"Translational oncology"}],"language":["eng"],"note":["Gesehen am 23.06.2025"]}]} | ||
| SRT | |a LOESCHMANNTESTINGOFS2013 | ||